Status:

COMPLETED

Influence of Persistent CMV-infection on Immune Senescence

Lead Sponsor:

University of Zurich

Collaborating Sponsors:

Division of Infectious Diseases and Hospital Epidemiology

Conditions:

Immune Senescence

Eligibility:

All Genders

70+ years

Phase:

PHASE4

Brief Summary

Recent studies indicate that persistent viral infections particularly with Cytomegalovirus (CMV) might have a negative impact on immune senescence (i.e. immunocompetence of elderly individuals). We wi...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age \> 70 years
  • Healthy according to a health questionnaire (completed before screening)
  • TBE-Vaccination indicated (exposure to TBEV-infested ticks possible)
  • Capable to make an informed decision and to understand the informed consent form
  • Informed consent signed by patient and study physician
  • Exclusion criteria:
  • Previous exposure to TBEV (natural or vaccination)
  • Immunodeficiency, history of autoimmune disease or current intake of immune-modulating drugs (corticosteroids a.s.o.)
  • Persistent (\> 3 months) pharmacological treatment with more than one drug of relevance (exception: combination antihypertensives)
  • Contraindication for TBEV-vaccination
  • Condition that would drastically interfere with clinic attendance and/or adherence to the protocol
  • Past medical history or current treatment for one of the following conditions: Chronic cardiac disease (Coronary heart disease, heart failure), chronic pulmonary disease (COPD), chronic kidney disease, diabetes mellitus, previous stroke, epilepsy, Parkinsons disease, dementia
  • Hemoglobin \<12 g/l
  • Random plasma glucose (RPG) \> 11.1 mmol/l OR fasting plasma glucose (FPG) \> 6.9 mmol/l (FPG required, if RPG is 7.0-11.0 mmol/l)
  • Calculated Creatinin-Clearance \< 50 ml/min
  • TBEV-serology positive

Exclusion

    Key Trial Info

    Start Date :

    May 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2010

    Estimated Enrollment :

    183 Patients enrolled

    Trial Details

    Trial ID

    NCT00461695

    Start Date

    May 1 2007

    End Date

    December 1 2010

    Last Update

    August 27 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital Zurich, Department of Infectious Diseases and Hospital Epidemiology

    Zurich, Switzerland